Arkema SA (OTCMKTS:ARKAY – Get Free Report) has received an average rating of “Reduce” from the six brokerages that are currently covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating on the company.
A number of equities research analysts recently commented on the stock. Barclays downgraded shares of Arkema from a “hold” rating to a “strong sell” rating in a research report on Tuesday, November 11th. Citigroup restated a “buy” rating on shares of Arkema in a research report on Friday, October 3rd. Zacks Research cut shares of Arkema from a “hold” rating to a “strong sell” rating in a research note on Tuesday, January 6th. Finally, Deutsche Bank Aktiengesellschaft lowered Arkema from a “buy” rating to a “hold” rating in a research note on Monday, November 24th.
Check Out Our Latest Research Report on Arkema
Arkema Stock Up 0.6%
Arkema (OTCMKTS:ARKAY – Get Free Report) last released its quarterly earnings results on Friday, November 7th. The basic materials company reported $1.19 EPS for the quarter, topping the consensus estimate of $0.98 by $0.21. The business had revenue of $2.52 billion during the quarter, compared to analysts’ expectations of $2.50 billion. Arkema had a return on equity of 5.15% and a net margin of 1.55%. As a group, research analysts anticipate that Arkema will post 8.36 EPS for the current year.
About Arkema
Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.
Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.
Featured Articles
- Five stocks we like better than Arkema
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.
